All Insights Article Marketer’s Paradox: How to Find the Right Method for Omnichannel Marketing Measurement
Marketer’s Paradox: How to Find the Right Method for Omnichannel Marketing Measurement
Marketer’s Paradox: How to Find the Right Method for Omnichannel Marketing Measurement
This guide helps marketing decision-makers select the right measurement technique to maximize omnichannel ROI. It introduces a strategic approach called the P.A.C.E. Framework to drive faster, smarter decisions.

Modern marketers operate under relentless pressure to answer a fundamental question: Are our omnichannel marketing investments truly driving incremental value and prescriptions, or are we flying blind with multimillion-dollar spends? With vast budgets poured into campaigns, channels, creatives, and tech, reporting only what happened is no longer enough. It’s essential to understand why something worked (or didn’t) and determine how to act on it next.
Across field force engagement – non-personal promotion (NPP), digital tactics, speaker programs, and patient support services – execution has scaled dramatically, but measurement often lags. Leaders are no longer judged on activity volume alone; they’re expected to deliver clarity on marketing ROI, inform brand strategy, and make real-time optimization decisions across highly regulated, privacy-constrained channels.
Yet, the explosion of dashboards, KPIs, and vendor tools often creates more noise than insight. Data silos across syndicated prescription (Rx) data, healthcare practitioner (HCP) targeting lists, customer relationship management (CRM) inputs from reps, digital campaign reports, and internal MDM systems often complicate rather than clarify evidence-based decision-making.
In such a complex environment, the competitive edge doesn’t lie in having more data but in choosing the best measurement technique.
Think of marketing decisions like a traffic light: green to double down on what works, yellow to monitor and sustain what performs, and red to stop what no longer delivers. But how do marketers make these calls and measure true impact without getting lost in a swirl of partial truths?
Q: Should I rebalance my $10M budget across channels for Q3?
Q: Are my paid social ads assisting conversions or stealing credit from organic?
Q: Which ad creative is yielding the lowest cost per acquisition (CPA) today?
Q: Would we have achieved the same conversions even without last month’s “Crystal Ball” campaign?
The answer lies in applying a clear framework as a structured decision-making tool to guide brand marketers in making smart and strategic measurement choices.
The P.A.C.E. Framework: A Smarter Way to Make Measurement Decisions
The P.A.C.E. Framework helps marketers assess their measurement needs across four key dimensions: purpose, access, cadence, and evidence. Each dimension answers a critical strategic question that shapes the right approach to measurement. Here's a look at how the framework works.
Figure 1: The P.A.C.E. Framework
Source: Axtria Inc.
1. PURPOSE: Which Decisions Are We Supporting?
This dimension clarifies the business objective and focuses on understanding the decision at hand. Are we deciding on long-term resource allocation, refining the current marketing mix, or evaluating the success of a short-term marketing campaign?
The purpose helps determine the measurement technique we should employ. Long-term strategic decisions like brand-level budget allocation may call for approaches like Marketing Mix Modelling (MMM). Meanwhile, short-term tactics like testing a new HCP email sequence or digital banner may benefit more from A/B tests or incrementality experiments.
2. ACCESS: What Kind of Data Is Available and at What Granularity?
Next, we must consider access – Do we have aggregate data, such as overall sales and media spend, or do we have granular, user-level data, such as impressions, clicks, and sessions? The level of access to data dictates the measurement approach. For instance, MMM works well with aggregate and historical or proxy data, while Multi-touch Attribution (MTA) requires user-level interaction data.
In pharma, access to patient- or prescriber-level data is limited due to HIPAA and other privacy laws. Instead, anonymized longitudinal Rx data, claims data, and 3rd-party syndicated data (e.g., IQVIA, Symphony) can often act as proxies, constraining granularity and demanding thoughtful modeling choices.
3. CADENCE: How Frequently Can Insights Be Obtained? And When Must Insights Be Acted Upon?
The cadence dimension focuses on the frequency of required insights. Some decisions need monthly feedback, while others may demand weekly or real-time insights. Are we making decisions every month, or is a quarterly report sufficient? For strategic decisions, insights may be required quarterly or annually, while a campaign-level measurement might need weekly or monthly inputs for real-time optimization.
4. EVIDENCE: What Confidence Level Is Required? And What Type of Proof Is Required for It?
The evidence dimension helps us define the level of rigor or the confidence threshold required. Is a directional, probabilistic model sufficient, or do we need robust causal evidence to justify our decisions? In some cases, we need high statistical confidence, as in MMM or customer lifetime value models. In others, a simpler directional approach may suffice, for example, when performance dashboards for campaign-level measurement are required.
Leadership teams often require high statistical confidence to support investment decisions, particularly when marketing outcomes feed into regulatory, medical, or payer discussions.
P.A.C.E. Framework Dimensions: Strategic Lens for Measurement Clarity | |||
---|---|---|---|
Dimension | Strategic Question Answered by the Dimension | What it Determines | Example Use Cases |
Purpose | Which decisions are we supporting? | Defines the nature and scope of the business decision: strategic allocation, tactical optimization, or campaign validation. | Budgeting, media planning, ROI justification, channel effectiveness |
Access | What data is available, and at what granularity? | Determines the appropriate model types based on aggregate vs. user-level data availability and online vs. offline sources. | Aggregate vs. user-level data detail, online/offline data availability |
Cadence | How frequently can the insights be obtained? And when must insights be acted upon? | Shapes the timing and operational applicability of measurement: real-time vs. quarterly insights. | Real-time optimization vs. post hoc campaign evaluation |
Evidence | What confidence level is required? And what type of proof is required for it? | Sets expectations for statistical rigor: directional trends vs. experimental validation. | Causal validation (A/B testing) vs. observational trends only |
Now that we've established the four key dimensions of the P.A.C.E. framework, let’s see how they guide marketers toward making the right choice for different types of decisions. Based on the P.A.C.E. inputs, marketers can map their decision needs to one of the four distinct measurement strategies, each with unique strengths and trade-offs.
We now explore how to apply this framework.
Using the P.A.C.E Framework to Guide Measurement Decisions
The P.A.C.E framework helps marketers align measurement techniques with the nature of the decision at hand, ensuring the right tool is applied in the right context. Marketing decisions typically fall into four distinct types, each requiring a different measurement approach. Here's how the framework maps to those decision levels.
Figure 2: P.A.C.E Framework mapped to Measurement Decisions
Source: Axtria Inc.
- Strategic-Level Decisions are made by marketers as they plan large-scale budgets across online and offline channels and as they seek to understand long-term ROI. The MMM technique plays a central role, as it is a top-down statistical model using historical data to quantify the impact of marketing channels and external factors, like seasonality, pricing, and weather, on outcomes like sales.
Typical questions marketers ask at this level include:
Q: “How should I split my $10M budget across channels for next quarter?”
Q: “How do I attribute Rx lift to different non-personal promotions like banner ads, speaker programs, and field visits across my oncology portfolio?”
This is where MMM can provide holistic insight by controlling for confounders like seasonality, competitive noise, and formulary access.
Applying the P.A.C.E. Lens to Strategic-level Decisions:- Purpose: Long-term ROI planning and resource allocation
- Access to data: Aggregate and historical (e.g., sales + media spend).
- Cadence or Refresh cycle: Quarterly or annual planning, aligning with strategic planning cycles and budget decisions
- Evidence: Primarily causal and driven by high statistical rigor/models.
- Actionability: Long-term
- Strengths of the technique: Holistic view, offline + online, doesn’t require user-level data.
- Limitations: Slow to update, not designed for in-flight campaign optimizations or tactical day-to-day decision-making.
- Journey-Level Decisions come into play when marketers need to optimize the digital mix and understand how different channels work together throughout a customer’s journey to assess each touchpoint’s contribution to conversions accurately. This dimension is essential in healthcare and pharma contexts, where patient and HCP customer journeys require distinct signals and privacy-safe methodologies.
Techniques that come in handy include MTA and probabilistic attribution (in cookie-less environments), which are ideal for tracking and assigning credit across digital touchpoints (e.g., email, search, social media).
In the cookie-less, privacy-first world, these methods help marketers track the relative contribution of non-personal digital tactics (emails, search, social media, display) without compromising compliance. Maintaining customer and patient privacy is crucial in therapeutic areas like oncology or rare diseases, where HCP engagement paths are complex, and each touchpoint may play a supportive versus final role in driving script behavior.
Example Decisions:
Q: “Are my paid social ads assisting conversions or stealing credit from organic?”
Q: “How do emails and banner ads work in tandem to drive HCP engagement post-field visit?”
To answer these questions, marketers must think of MTA-like assessments.
Applying the P.A.C.E. Lens to journey-level Decisions:- Purpose: To optimize the efficiency of digital channels, particularly in the mid-funnel, and refine retargeting strategies
- Access: Cookie- or ID-level user interaction data
- Cadence: Typically, weekly to monthly, depending on campaign activity
- Evidence: Directional attribution not always causal
- Actionability: Short- to mid-term (focusing on immediate adjustments in strategy)
- Strengths: Granular, cross-touchpoint insights can inform budget shifts
- Limitations: Often digital-only, cookie- or ID-dependent, vulnerable to privacy regulations
- Campaign-Level Decisions become relevant when marketers need to evaluate the effectiveness of specific campaigns over a few weeks/months and optimize performance, either for immediate action or to prove impact.
Common questions include:
Q: “Which ad creative is driving the lowest cost per acquisition (CPA) today?”
Q: “Would we have achieved these conversions even without last month’s campaign? How can we measure marketing campaign effectiveness?”
Q: “Did rep-triggered emails after a field call lead to higher new-to-brand prescription lift?”
Applying the P.A.C.E. Lens to Campaign-level Decisions:- Purpose: To assess a specific campaign’s performance and optimize it in real time.
- Access: Real-time or near-real-time platform data.
- Cadence: Two choices – (a) daily to weekly with CPA optimizations; (b) weekly to monthly with causal studies and deeper analysis
- Evidence: can vary from observational dashboards to structured experiments. The ideal techniques for campaign-level decisions often revolve around incrementality testing and campaign performance analytics
Campaign Performance Analytics – CPA (Observational) Incrementality Testing / Campaign Lift Analysis (Causal) - Pulls real-time data from platforms to help manage active campaigns
- Best for on-the-fly optimizations, creative, and targeting tweaks
- Techniques include real-time performance monitoring through KPI dashboards with metrics like CTR, CPA, ROAS
Strengths: Fast feedback for creatives and targeting
Limitations: Doesn’t show causality, correlation only- Experimental setups with test/control groups to isolate the actual effect of a campaign
- Best for proving a campaign’s actual business value
- Techniques include holdout experiments, geo tests, and brand lift studies
Strengths: Causal, privacy-safe, excellent for stakeholder confidence
Limitations: Requires careful, clean setup and may not scale for every testCTR: Click Through Rate | CPA: Cost Per Acquisition | ROAS: Return on Ad Spend Note: In the pharma world, all incrementality tests and touchpoint attribution assessments must comply with promotional regulations, content approval processes, and field force coordination. - Actionability: Immediate, with direct adjustments to creatives, audiences, and channels.
- Strengths: Fast and clear readouts, which are strong for testing creatives, channels, or targeting.
- Limitations: Needs scaled and controlled setup; findings may not generalize
- Future Value Decisions are made by marketers when they focus on optimizing long-term business health and sustained revenue, where techniques like customer lifetime value modeling and predictive analytics become indispensable. These methods leverage behavioral and transactional data to forecast revenue per user and optimize acquisition channels to drive future value.
Marketers turn to future value modeling and measurement techniques when seeking answers to questions like:
Q: “Which channels attract customers who will stay and spend over the next 6+ months?”
Q: “Can we predict future Rx volume by analyzing early content interaction?”
Predictive models surface those insights and help us act on them.
Applying the P.A.C.E. Lens to Future-value Decisions:- Purpose: Maximize long-term customer value, enhance retention, nurture loyalty of high-value customers
- Access: CRM systems and historical behavioral data
- Cadence: Quarterly or Semi-annual with long-term payoff
- Evidence: Statistically robust and forecast-ready
- Actionability: Long-term customer strategies
- Strengths: Drives business model evolutions (loyalty, etc.)
- Limitations: Dependent on robust historical and behavioral data; dependent on assumptions about churn, repeat rate, etc.
These techniques are particularly effective when business shifts focus toward retention and strategic acquisition. Predictive analytics delivers actionable insights that shape long-term customer strategies when marketers ask, “Which channels bring in customers who’ll be valuable 6+ months from now?”
Together, these scenarios – from strategic budget planning to in-market optimizations – illustrate marketers’ diverse measurement needs. Choosing the fit-for-purpose measurement strategy is made easy with the P.A.C.E framework.
The Path Forward: Elevating Pharma Measurement Maturity
Marketing leaders must move beyond fragmented reporting toward holistic, outcome-driven measurement – a shift especially vital in pharma, where omnichannel strategies span rep interactions, non-personal promotion, patient support, and access initiatives. Without a clear framework, however, teams risk chasing metrics disconnected from business priorities or investing in tools, data products, and solutions misaligned with data readiness, analytical maturity, or governance standards.
Organizations can significantly strengthen their measurement maturity by institutionalizing the P.A.C.E framework and anchoring every measurement choice in Purpose, Access, Cadence, and Evidence. This process fosters alignment across stakeholders, clarifies trade-offs, and accelerates informed decision-making across commercial functions.
Ultimately, brands that thrive will not be those with the most data but those who ask the right questions and apply the most effective techniques to answer them at the right time. The true differentiator lies in leveraging measurement not just as a reporting function but as a lever for proactive value creation across the brand’s lifecycle.

Jasmeen Kaur
Jasmeen Kaur (Associate Director, Axtria) is a marketing analytics leader who advises global brands on data-driven growth strategies. She designs tailored measurement frameworks and leverages AI-powered analytics to improve omnichannel performance, optimize marketing outcomes, and deepen customer insights. Her work has enabled smarter decisions and lasting ROI for both Fortune 500 leaders and fast-growing disruptors.
Complete the brief form to download the white paper
Related insights
Stay current on topics you care about
Recommended insights

Article
Balancing Effort Versus Value: Why On-Demand Marketing Mix Modeling Software Is Essential for Brand Success

Blog